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Abstract
Background: The fermentation of dietary fiber to various organic acids is a beneficial function provided by the
microbiota in the human large intestine. In particular, butyric acid contributes to host health by facilitating
maintenance of epithelial integrity, regulating inflammation, and influencing gene expression in colonocytes. We
sought to increase the concentration of butyrate in 20 healthy young adults through dietary supplementation with
resistant starch (unmodified potato starch—resistant starch (RS) type 2).
Methods: Fecal samples were collected from individuals to characterize butyrate concentration via liquid
chromatography and composition of the microbiota via surveys of 16S rRNA-encoding gene sequences from the
Illumina MiSeq platform. Random Forest and LEfSe analyses were used to associate responses in butyrate
production to features of the microbiota.
Results: RS supplementation increased fecal butyrate concentrations in this cohort from 8 to 12 mmol/kg wet
feces, but responses varied widely between individuals. Individuals could be categorized into three groups based
upon butyrate concentrations before and during RS: enhanced, high, and low (n = 11, 3, and 6, respectively). Fecal
butyrate increased by 67 % in the enhanced group (from 9 to 15 mmol/kg), while it remained ≥11 mmol/kg in the
high group and ≤8 mmol/kg in the low group. Microbiota analyses revealed that the relative abundance of
RS-degrading organisms—Bifidobacterium adolescentis or Ruminococcus bromii—increased from ~2 to 9 % in the
enhanced and high groups, but remained at ~1.5 % in the low group. The lack of increase in RS-degrading bacteria
in the low group may explain why there was no increase in fecal butyrate in response to RS. The microbiota of
individuals in the high group were characterized by an elevated abundance of the butyrogenic microbe
Eubacterium rectale (~6 % in high vs. 3 % in enhanced and low groups) throughout the study.
Conclusions: We document the heterogeneous responses in butyrate concentrations upon RS supplementation
and identify characteristic of the microbiota that appear to underlie this variation. This study complements and
extends other studies that call for personalized approaches to manage beneficial functions provided by gut
microbiomes.
Background
The microbiota in the large intestine provides several
functions that are beneficial to human health such as pro-
ducing short-chain fatty acids, modifying primary to sec-
ondary bile acids, and providing colonization resistance to
some enteric pathogens [1, 2]. Managing this community
of microbes to maintain and improve these beneficial
functions could promote health and reduce the incidence
of preventable diseases including obesity and type 2 dia-
betes [3], colon cancer [4], chronic and acute undernutri-
tion [5], and infections by Clostridium difficile [6].
One of the beneficial functions derived from the co-
lonic microbiota is the production of butyric acid that is
generated from the fermentation of dietary fiber. The
conjugate base of the acid—butyrate—is the preferred
energy source for colonocytes [7]. Butyrate improves the
intestinal barrier by facilitating tight-junction assembly
[8], suppresses inflammatory and allergic responses by
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inducing differentiation of colonic regulatory T cells [9],
regulates cell apoptosis [10], and stimulates production
of anorectic hormones [11]. Indeed, reduced concentra-
tions of butyrate have been associated with the incidence
of graft-versus-host disease [12, 13], kwashiorkor [14],
colon cancer [15], and obesity [11]. Especially in these
circumstances, increased butyrate production in the
large intestine may be beneficial to human health.
One approach to increasing butyrate production is to
deliver more fermentable carbohydrates to gut micro-
biomes. Here, we report on the impact of dietary supple-
mentation with resistant starch (unmodified potato
starch; RS type 2) on fecal butyrate concentrations and
composition of the gut microbiota in 20 healthy young
adults. RS consists of starch that is resistant to hydroly-
sis by human enzymes and passes through the small in-
testine unabsorbed. In the large intestine, RS can be
metabolized and then fermented by microbes to a variety
of products, including butyric acid [16]. In this study, we
find that the response to RS supplementation varies be-
tween individuals in ways that can be explained, at least
in part, by variation in the composition of their micro-
biota. Recognizing inter-individual variability in re-
sponses to fiber supplementation and determining the
microbiota characteristics that underlie it are essential
first steps towards personalized plans for managing gut
microbiomes for desirable functionality, including the
production of butyrate.
Methods
Participants
Prospective volunteers were students in research-based
sections of Introductory Biology 173 at the University of
Michigan. Individuals with a self-reported history of
bowel disorders such as irritable bowel syndrome, in-
flammatory bowel disease, or colorectal cancer were ex-
cluded from the study. Twenty individuals (10 males, 10
females) participated in the 3-week study. The age range
was 19–20 years, and the BMI range was from 19–63.
Each participant gave his or her written, informed
consent before participating in the study. This research
was carried out in compliance with the Helsinki Declar-
ation and was approved by the Institutional Review
Board of the University of Michigan Medical School
(HUM00094242).
Study design
Participants consumed their habitual diet throughout
the study period. During the intervention phase, raw un-
modified potato starch (Bob’s Red Mill, Milwaukie, OR)
was gradually added to their diet (day 1—12 g, day
2—24 g, day 3—48 g; Fig. 1). This potato starch contains
approximately 50 % resistant starch (type 2) by weight.
After the acclimatization period, the subjects consumed
48 g of potato starch—24-g doses twice per day—for
seven more days. Participants were provided a 1-
tablespoon scoop, which they used to measure out the
appropriate amount of potato starch (each tablespoon
≈12 g) and consumed it after mixing the starch with cold
water.
Fecal collection
Participants were provided waxed tissue paper (Epitope
Diagnostics, San Diego, CA), which was laid down on
the water in the toilet bowl prior to defecation. This
paper sticks to the sides of the toilet bowl so that the
fecal sample is not readily contaminated by water in the
toilet. Fecal samples were collected using the deoxyri-
bose nucleic acid (DNA) Genotek Omnigene Gut
Collection kits (DNA Genotek, Ontario, Canada) follow-
ing the manufacturer’s instructions. The DNA Genotek
tube contains 2 mL of a stabilization buffer and a steel
ball to facilitate mixing of the fecal material with the
buffer. Approximately, 0.67 g of fecal material was col-
lected per tube. The kits were returned to a −20 °C
freezer within 24 h of collection. Frozen samples were
thawed and aliquots were withdrawn for DNA extrac-
tion, measurement of fermentation products, and to cre-
ate sample archives.
DNA extraction, PCR, sequencing, and sequence
processing
For DNA extraction, 0.25 mL of the fecal suspension in
the DNA Genotek tube was deposited into a MoBio
PowerMag Soil DNA Isolation Bead Plate. DNA was ex-
tracted following MoBio’s instructions on an epMotion
5075 liquid handling workstation (Eppendorf, Hauppauge,
NY). The V4 region of the 16S-ribosomal RNA (rRNA)
encoding genes was amplified from each sample using
the dual-indexing sequencing strategy [17]. Sequen-
cing was performed on the Illumina MiSeq platform,
using a MiSeq Reagent Kit V2 500 cycles (Cat# MS-
102-2003), according to the manufacturer’s instruc-
tions. Sequences were curated using mothur v1.31.2
[18] and clustered into operational taxonomic units at
≥ 97 % sequence identity using the average neighbor
algorithm.
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Fig. 1 Experimental design. Participants supplemented their habitual
diets with resistant starch. Filled symbols represent points at which
fecal samples were collected
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Measurement of fermentation products
One millimeter of fecal suspension was aliquoted from
each DNA Genotek OmniGut tube and centrifuged at
4 °C for 10 min (4500×g). The supernatant fraction was
withdrawn and passed sequentially through 1.2, 0.65,
and 0.22-μm hydrophilic low protein-binding Durapore
membrane filters (EMD Millipore, Darmstadt, Germany).
Filtered samples were stored at −20 °C until analysis.
Once thawed, samples were maintained at 4 °C in an
autosampler. A Shimadzu HPLC (Shimadzu Scientific
Instruments, Columbia, MD) equipped with a dual UV
(214 nm for short-chain fatty acids (SCFAs))/refractive
index detector (for ethanol) and an Aminex HPX-87H
column (Bio-Rad Laboratories, Hercules, CA) heated to
50 °C was used to measure acetic, propionic, and butyric
acids and ethanol in the filtrate. The mobile phase was
0.01 N H2SO4 at a flow rate of 0.6 ml/min, and the injec-
tion volume was 10 μl. Samples were randomized in re-
gard to injection order, and the average value from two
technical replicates was used in all subsequent analyses.
Ethanol, which was a component of the stabilization buf-
fer, served to monitor injection volumes. Samples in which
the peak height for ethanol was less than 70 % of the aver-
age peak height for ethanol in all samples were excluded
from further analysis. Eight external standards (0.1–
20 mM) for acetic, propionic, and butyric acids were used
to generate the standard curve. These standards were run
after every 100 samples. LC Solutions Software (Shimadzu
Scientific Instruments, Columbia, MD) was used to curate
the data and calculate concentrations based on the stand-
ard curve generated during the run. The concentrations
were then normalized by the average weight of the fecal
samples (0.67 g) collected in the DNA Genotek tubes.
Statistical analyses
All statistical analyses were performed using RStudio
version 0.99.489 [19] and the software PAST [20]. To
evaluate the impact of RS supplementation on acetate,
propionate, and butyrate concentrations in the study
population, a nested repeated measures analysis of vari-
ance (ANOVA) was used. This revealed that fecal butyr-
ate and acetate concentrations increased with RS intake
in the study population (p < 0.05). For all subsequent
analyses, the median value of butyrate for each person
before and during RS consumption was used so that the
number of samples compared was not artificially in-
flated. Paired or unpaired t tests were employed as ap-
propriate. To determine if RS intake altered microbial
community composition, a permutational analysis of
variance (PERMANOVA) analysis was conducted with
the Bray-Curtis similarity index. Each individual was
used as the blocking factor to account for repeated mea-
sures of microbiota composition from each individual.
This analysis revealed that RS intake altered the
composition of gut microbiota in the study population
(p < 0.05). For further analyses, we used the median
abundance of each operational taxonomic unit (OTU) in
each individual before and during RS consumption. To
identify specific OTUs that had changed with RS con-
sumption, LEfSe and Random Forest analyses were per-
formed for each individual separately (comparing their
four samples before and four samples during RS con-
sumption). LEfSe [21] was implemented within mothur
using the correction for multiple comparisons. PERMA-
NOVA, analysis of similarity (ANOSIM), and permuta-
tional analyses of dispersions (PERMDISP) analyses were
performed with the package vegan in R. Random Forest
was implemented using the package randomForest in R.
Results
The impact of RS on the composition of the gut micro-
biota and the concentration of three short-chain fatty
acids (acetic, propionic, and butyric) in feces was deter-
mined in 20 healthy young adults. RS was gradually intro-
duced into their regular diets during an acclimatization
period of 3 days (Fig. 1). Thereafter, study participants in-
cluded 48 g of unmodified potato starch in their daily diet
(~24 g as RS) for 7 days. Four fecal samples were collected
before the introduction of RS and another four during the
period of maximum RS supplementation (Fig. 1).
There was considerable intra-individual variability in
the concentration of acetate, propionate, and butyrate
(coefficient of variation = 20–90 %). This variability is
not unexpected because fecal SCFA concentrations are
influenced by host absorption, transit time through the
GI tract, host diet, and time since last meal. Due to this
variability and the number of samples, Student’s t tests
did not reveal measurable differences in the concentra-
tion of SCFA in response to RS supplementation for an
individual (four samples before vs. four during RS for
each individual; p ≥ 0.10 for all individuals). However, a
repeated measures ANOVA showed that RS supplemen-
tation increased the fecal concentration of butyrate by
50 % and acetate by 26 % in the study population as a
whole (p = 0.02 and 0.03, respectively; Table 1). The
concentrations of propionate did not change signifi-
cantly in this cohort (p = 0.85; Table 1).
Table 1 Effect of dietary supplementation with RS on
concentration of select fermentation products (mmol/kg
wet feces)
Fermentation
product
Before RS During RS Change p value (repeated
measures ANOVA)Median ± IQR Median ± IQR
Butyric acid 8 ± 6 12 ± 7 50 % 0.03
Acetic acid 27 ± 6 34 ± 10 26 % 0.02
Propionic acid 13 ± 6 12 ± 5 −8 % 0.85
IQR interquartile range
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Like the fecal SCFA concentrations, there was also
some intra-individual variability in the composition of
microbiota. However, at least 75 % of OTUs were con-
sistently detected in all samples from an individual with
the coefficient of variation in their relative abundances
ranging from 39 to 65 %. Unlike the SCFAs, where stat-
istical tests did not detect differences in response to RS
for an individual, ANOSIM tests showed that RS supple-
mentation altered the composition of microbiota in most
individuals in the study (ANOSIM with Bray-Curtis
similarity; four samples before vs. four during RS for
each individual; p < 0.10 for 16 out of 20 individuals).
This conclusion was corroborated by results from a
PERMANOVA analysis to determine if RS supplementa-
tion altered the composition of microbiota in the overall
study population. In order to incorporate intra-
individual variability, each individual was considered as
the blocking factor in the PERMANOVA. This analysis
revealed that the composition of the gut microbiota was
altered with RS supplementation in our study population
(PERMANOVA using Bray-Curtis similarity blocking for
each individual; p = 0.001). A PERMDISP analysis further
revealed that the PERMANOVA was not affected by dif-
ferences in the dispersion of communities before and
during RS (PERMDISP p = 0.44).
The relative abundance of OTUs belonging to the
phylum Actinobacteria increased with RS, and there was
a small decrease in the abundance of Firmicutes. No
changes were detected in the relative abundances of
Bacteroidetes or Proteobacteria (Table 2). Finally, RS
supplementation did not change the overall richness or
evenness of the microbial community in the study popu-
lation (repeated measures ANOVA Chao1 index before
vs. during p = 0.49; Simpson’s index before vs. during
p = 0.96).
Therefore, despite the intra-individual variability in
fecal SCFA concentrations and composition of micro-
biota, repeated measures ANOVA and PERMANOVA
reveal that RS consumption led to increases in fecal bu-
tyrate concentrations and altered the composition of the
microbiota in the study population. However, the start-
ing concentrations of butyrate and the changes in butyr-
ate during RS varied widely between individuals (Fig. 2).
Baseline butyrate concentrations were not predictive of
butyrate concentrations during RS supplementation
(R2 = 0.08, p = 0.20).
To identify characteristics of the microbiota that may
underlie the variable responses to RS, we first used Ran-
dom Forest regression to identify relationships between
the abundances of OTUs and butyrate concentrations
before and during consumption of RS. No OTUs were
particularly strong predictors of butyrate concentrations
either before or during RS consumption. Butyrate con-
centrations before RS were weakly related to baseline
abundances of OTU 4 (Eubacterium rectale) (R2 = 0.14;
p = 0.10). Unexpectedly, this relationship was not detect-
able during RS supplementation.
Population-wide relationships between OTUs and bu-
tyrate concentrations could be masked by the heterogen-
eity of both variables between individuals. We therefore
looked for correlations between features of the micro-
biota and butyrate concentrations in subsets of partici-
pants that had similar responses in fecal butyrate
following RS supplementation. The study population
was separated into three groups using k-means cluster-
ing based on butyrate concentrations before and during
RS. An elbow plot [22] revealed that there were three
“clusters”. The categories identified were enhanced, high,
and low (Fig. 3a, b). The concentration of butyrate in
the “enhanced” group (n = 11) increased significantly
following consumption of RS (from 9 to 15 mmol/kg
wet feces, paired t test p = 0.0003). Individuals in the
“high” group (n = 3) maintained butyrate concentrations
≥11 mmol/kg wet feces during the course of the study.
Individuals in the “low” group (n = 6) had less than or
equal to 8 mmol butyrate/kg wet feces both before and
during RS (paired t test p = 0.14; Fig. 3c).
The OTUs that distinguished these three clusters were
identified using Random Forest analysis and LEfSe
(Table 3). Random Forest revealed OTU #7 as the most
prominent feature of the microbiota distinguishing the
low from the enhanced group (Table 3). Sequences
within this OTU are identical to those from Bifidobac-
terium adolescentis. The relative abundance of this OTU
before RS was similar in all three groups (~0.7–1.4 %;
Table 2 Effect of dietary supplementation with RS on relative
abundance of four dominant bacterial phyla
Phylum Before RS During RS (%) Change p value
Median ± IQR Median ± IQR paired t test
Actinobacteria 1.3 ± 0.6 6.2 ± 0.6 377 % 0.02
Firmicutes 37.1 ± 10.7 33.2 ± 5.2 -11 % 0.04
Bacteroidetes 53.3 ± 13.2 51.5 ± 9 -3 % 0.82
Proteobacteria 4.7 ± 4.1 4.8 ± 4.1 2 % 0.82
IQR interquartile range
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t test p > 0.27; Fig. 4a). However, the enhanced and
high groups had dramatically higher abundances of
this OTU during RS (average 8.9 % in enhanced and
7.8 % in high; p < 0.05; Fig. 4a). The abundance of
this OTU did not change in the low group (average
before RS = 1.5 %, average during = 3.7 %, p = 0.13).
This finding was further corroborated with a LEfSe
analyses comparing four samples before to four dur-
ing RS consumption for each individual. As one
would expect, the abundance of OTU 7 increased in
8 out of 11 individuals in the enhanced group, 2 out
of 3 individuals in the high group, but in only 2 out
of 6 individuals in the low group (LEfSe p < 0.05 cor-
recting for multiple comparisons).
Cultivars of B. adolescentis are capable of breaking
down RS [23]. OTU #7 in which sequences were identi-
cal to the 16S rRNA encoding gene of B. adolescentis
was detected in 14 out of 20 total individuals and in-
creased in abundance in 12 individuals. This OTU did
not increase in individuals U026 and U024 (LEfSe
p > 0.05 correcting for multiple comparisons). However,
OTU #7 [B. adolescentis] was not detected in six individ-
uals. In these individuals, LEfSe was used to find other
OTUs that increased in abundance during RS supple-
mentation, since these could be RS-degrading bacteria.
In three individuals in whom B. adolescentis sequences
did not increase, OTU 19 increased in abundance (LEfSe
p < 0.05 correcting for multiple comparisons). Sequences
in that OTU are identical to Ruminococcus bromii, an-
other group of RS-degrading bacteria [23]. In individual
U005, neither B. adolescentis nor R. bromii increased in
abundance with RS. A potential candidate for a RS-
degrading organism in this individual is OTU 50, whose
average abundance increased from 2.6 to 7.1 % albeit
not statistically significant (p = 0.29). Sequences in this
OTU are most closely related to Ruminiclostridium
[Eubacterium] siraeum. This organism has not been
reported to degrade RS, but it is in the same taxonomic
family as R. bromii.
Since B. adolescentis and R. bromii are the strongest
candidates for RS-degrading organisms in this study, we
summed the abundance of these two organisms for each
individual (Fig. 4b). Individuals in all three groups start
with a similar abundance of these RS-degrading mi-
crobes. RS elicits dramatic increases in their abundance
in high and enhanced groups, but not in the low group
(Fig. 4b).
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Table 3 Results of Random Forest regression and LEfSe to
identify OTUs that distinguish the three response groups
Comparison Distinguishing microbiota features
LEfSe Random Forest
Low vs. enhanced None identified [OTU 7] during RS
High vs. low [OTU 4] before and during RS [OTU 4] before and during RS
[OTU 3] before RS
‡
High vs. enhanced [OTU 4] before and during RS [OTU 4] before and during RS
‡A post-hoc ANOVA analysis revealed that the abundance of OTU #3 was not
significantly different between the groups being compared (p > 0.10). Hence,
this OTU was not considered further
Venkataraman et al. Microbiome  (2016) 4:33 Page 5 of 9
Random Forest and LEfSe also revealed that OTU 4
distinguished the high group from the enhanced and low
groups (Table 3). Sequences within this OTU are identi-
cal to E. rectale—a known and prominent butyrogenic
microbe in human guts [24]. E. rectale was more abun-
dant in individuals in the high group than in the other
two groups—both before and during RS (Fig. 5b). While
individuals in the high group fall into a very distinct
cluster in the k-means clustering (Fig. 3), there are only
three individuals in this group. This limited sample size
does constrain the strength of the finding that E. rectale
is more abundant in the high group vs. the other two
groups. Some individuals in the enhanced group exhib-
ited increases in abundances of E. rectale during RS
supplementation (Fig. 5a, LEfSe p < 0.05 correcting for
multiple comparisons), but in general, its abundance did
not change as a result of RS addition to diet in any of
the three groups (Fig. 5b). We looked specifically at
other butyrogenic organisms known to be present in the
human colon such as Faecalibacterium prausnitzii [25].
An OTU with the same V4 16S-rRNA encoding gene se-
quence as F. prausnitzii was present at about 3–6 %
relative abundance in all three groups, but did not
change with RS in any of the groups (t test p > 0.15).
Since B. adolescentis—the prominent RS-degrading mi-
crobe in our cohort—produces lactate as the primary
fermentation product, we also investigated if organisms
known to produce butyrate from lactate increased in
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abundance. OTUs in which sequences were most closely
related to Eubacterium halii and Anaerostipes caccae
were present at less than 0.4 % abundance in our cohort
and did not change with RS (paired t test p = 0.4).
Discussion
The impact of dietary supplementation with resistant
starch on fecal butyrate concentrations and the compos-
ition of the microbiota was examined in 20 healthy
young adults. In this cohort, the average ratios of aceta-
te:propionate:butyrate before and during RS supplemen-
tation were 58:25:15 and 58:22:20, respectively. These
ratios agree well with previously documented ratios of
~60:20:20 in human feces [26–29]. In response to RS
supplementation, the concentration of fecal butyrate in-
creased from 8 to 12 mmol/kg wet feces in the overall
study population (repeated measures ANOVA p = 0.02).
The inter-individual variation in butyrate concentrations
before and during RS was striking (Fig. 2). Most previ-
ous studies with RS have documented only population-
wide response in butyrate concentrations [16], while one
other study reported considerable heterogeneity between
individuals in regard to fecal butyrate concentrations
[30]. This pronounced inter-individual variability sug-
gests that a single approach to improving beneficial
functions from the microbiome is unlikely to be univer-
sally successful. Rather, personalized approaches may be
needed to manage microbiomes for health. In line with
this endeavor, we attempted to identify features in the
microbiota that could explain different responses to diet-
ary supplementation with RS.
Random Forest was used to identify relationships be-
tween butyrate concentrations and OTUs in the study
population. Weak relationships were identified between
butyrate concentrations before RS and the abundances
of OTU 4 (E. rectale). Random Forest failed to reveal
any relationships between OTU abundances and butyr-
ate concentrations during RS supplementation. It is pos-
sible that the number of individuals in this study (n = 20)
may have been too small to detect robust correlations
between butyrate and the abundance of OTUs at the
population level. Alternatively, it is not necessary that
the abundance of a single organism be correlated with
butyrate concentrations. After all, the potential for pro-
ducing butyrate is fairly widespread within the phylum
Firmicutes [31]. Rather, we expect that the abundance of
genes encoding butyryl-CoA:acetate CoA transferase
(but) and butyrate kinase (buk) would be correlated to
butyrate concentrations.
Our next step was to create groupings in the data
based upon similar responses to RS. This clustering ap-
proach should constrain the variability within each group
and increase the probability of identifying microbiota fea-
tures that characterize each type of response. K-means
clustering using butyrate concentrations before and dur-
ing RS identified three groups: enhanced, high, and low.
Butyrate increased on average from 9 to 15 mmol/kg wet
feces in the enhanced group, whereas butyrate concentra-
tions remained consistently high or low in the other two
groups (≥11 and ≤8 mmol/kg wet feces, respectively;
Fig. 3). With these clusters, we were able to identify fea-
tures of the microbial communities that differentiated the
three groups.
The relative abundance of proposed RS-degrading
bacteria—B. adolescentis or R. bromii—increased with
RS supplementation in the enhanced and high groups
(from 2 to 9 %), but not in the low group (~1.5 %
throughout; Fig. 4). This finding complements and ex-
tends previously published reports on the effects of RS
supplementation on the composition of the human gut
microbiota. In a study with overweight adult males, only
individuals with detectable abundances of R. bromii in
their gut microbiota were able to degrade RS (type
3—Novelose 330; Walker et al. [32]). In another study
with ten human subjects (five males and females; 28–
38 years old), dietary supplementation with either type 4
RS (FiberSym RW) or type 2 RS (HiMaize260) increased
the relative abundance of B. adolescentis and R. bromii,
respectively (Martinez et al. [33]). These in vivo studies
are nicely complemented by in vitro microcosm studies,
which showed that isolates of R. bromii and B. adoles-
centis are capable of degrading several forms of RS [23].
Thus, different types of resistant starches are likely to
promote the growth of B. adolescentis or R. bromii, with
both organisms exhibiting substrate specificity depending
upon the type and source of RS.
The relative abundance of RS-degrading organisms
and butyrate concentrations did not increase in the low
group. This suggests that their microbiota did not break
down RS and so could not lead to increased butyrate
production. This suggestion is supported by the fact that
the concentrations of neither acetate nor propionate in-
creased in the low group. So why does the abundance of
RS-degrading organisms remain at 1.5 % in the low
group? Possible explanations include limitation by antag-
onistic microbes or lack of synergistic microbes. Our
attempts to identify antagonistic and synergistic interac-
tions by constructing correlation networks [34] between
RS-degrading organisms and other OTUs did not yield
any compelling relationships.
In addition to RS-degrading organisms, another OTU
(OTU #4) was identified as distinguishing the high
group from the enhanced and low groups (Table 3,
Fig. 5). Its V4 sequence is identical to that of E. rectale,
well established as a prominent butyrogenic bacterium
in the human gut microbiome [24, 35]. Its relative abun-
dance in the high group was consistently about 6 %,
compared to 3 % in the other two groups. Surprisingly,
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the abundance of E. rectale did not change in any of the
groups in response to RS—even though butyrate con-
centrations increased appreciably in the enhanced group
(from 9 to 15 mmol/kg wet feces). E. rectale generates
butyrate from acetate, and there is a net gain of ATP in
that process [35]. So if E. rectale was responsible for in-
creased butyrate production in the enhanced group with
RS, one might expect an increase in its relative abun-
dance. We offer two possible explanations for the in-
creased butyrate production in the enhanced group
without a measurable increase in the abundance of E.
rectale. First, changes in the relative abundance of E. rec-
tale may be subtle and masked by the dramatic increase
in the abundance of RS-degrading organisms (~from 2
to 10 % in the enhanced group). It is also possible that
populations of E. rectale take longer to respond to RS
supplementation. We used an acclimatization period of
only 3 days during which the amounts of RS in diet were
gradually increased, and after this period, four fecal sam-
ples were collected. It remains to be seen whether there
is a detectable increase in the abundance of E. rectale
following a longer duration of RS consumption. Also, as
mentioned earlier, it is well documented that butyrate
production is widespread within the phylum Firmicutes
in human gut microbiomes. Therefore, rather than a sin-
gle organism, if more acetate is being converted to bu-
tyrate, the genes encoding butyryl-CoA:acetate CoA
transferase (but) and butyrate kinase (buk) should in-
crease in abundance with RS supplementation.
Conclusions
Our data show that dietary supplementation with RS
type 2 as unmodified potato starch increases fecal butyr-
ate concentration, but with remarkable inter-individual
variation. We were able to infer potential explanations
for some of these differential effects by investigating the
composition of microbiota. Fecal butyrate concentra-
tions increased by an average of 67 % in a subset of the
study population (n = 11 of 20; 9 to 15 mmol/kg wet
feces). Most individuals in this group showed a dramatic
increase in the relative abundance of the RS-degrading
organisms—B. adolescentis or R. bromii. In five of these
individuals, the prominent butyrogenic microbe E. rec-
tale also increased in abundance. Another subset of the
population (3 of 20) consistently maintained high butyr-
ate concentrations both before and with RS (≥12 mmol/
kg wet feces). In this subset, RS-degrading organisms in-
creased in abundance, suggesting that RS is being de-
graded. But there was no concomitant increase in fecal
butyrate concentrations. These individuals may be ex-
periencing a plateau effect [36] in butyrate production
even before RS is administered. In fact, the microbiota
structures of these individuals also did not change as
much with RS (ANOSIM R = 0.17) as compared to
changes in the microbiota in the enhanced group
(ANOSIM R = 0.64). It is tempting to suggest that the
microbiota of these individuals are performing well with
regard to butyrate production, and they do not benefit
from additional dietary input of fermentable carbohy-
drates. A third subset of our study population (6 of 20)
had consistently low concentrations of butyrate even
when consuming RS (≤8 mmol/kg wet feces). In this
group, RS-degrading organisms did not increase in
abundance, suggesting that their microbiota did not
break down RS. Based upon this result, we propose that
increasing butyrate in these individuals will require
either (i) testing another form of dietary fiber such as
inulin or arabinoxylan that their microbiota might de-
grade, (ii) a synbiotic approach that combines a dietary
fiber with the appropriate fiber-degrading bacteria, or
(iii) targeted removal of microbes if any are antagonistic
to RS-degrading organisms. The findings of this study il-
lustrate the importance of studying individual responses
to dietary modifications. This will uncover the mecha-
nisms that underlie these responses and in time provide
actionable insights towards precision management of
microbiomes.
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